OxyContin, prescription opioid abuse and economic medicalization

Medicolegal and Bioethics:31 (2012)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.2147/mb.s32040

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 101,518

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

The prescription opioid epidemic: an update.Geoffrey Poitras - 2018 - Medicolegal and Bioethics:21-32.
Prescription Opioid Abuse in the Emergency Department.Barth L. Wilsey, Scott M. Fishman & Christine Ogden - 2005 - Journal of Law, Medicine and Ethics 33 (4):770-782.
"Deserving Patients" or "Potential Addicts?": Narrative Analysis of an FDA Hearing on Prescription Opioid Labeling.Loren Wilbers - 2020 - Narrative Inquiry in Bioethics 10 (2):145-158.
The Potential for Medicolegal Abuse: Diffusion Tensor Imaging in Traumatic Brain Injury.Hal S. Wortzel, A. John Tsiouris & Christopher G. Filippi - 2014 - American Journal of Bioethics Neuroscience 5 (2):9-15.
Defining Misprescribing to Inform Prescription Opioid Policy.Kelly K. Dineen - 2018 - Hastings Center Report 48 (4):5-6.
Promoting diseases to promote drugs: The role of the pharmaceutical industry in fostering good and bad medicalization.Emilia Kaczmarek - 2022 - British Journal of Clinical Pharmacology 88 (1):34-39.
Book Review: Prescription Drug Abuse and DependenceGreenfieldDaniel P., ed., Prescription Drug Abuse and Dependence: How Prescription Drug Abuse Contributes to the Drug Abuse Epidemic : 170 pp. [REVIEW]Bonnie B. Wilford - 1996 - Journal of Law, Medicine and Ethics 24 (1):62-64.
Opioid Contracts and Random Drug Testing for People with Chronic Pain — Think Twice.Mark Collen - 2009 - Journal of Law, Medicine and Ethics 37 (4):841-845.
The Public Health Value of Opioid Litigation.Rebecca L. Haffajee - 2020 - Journal of Law, Medicine and Ethics 48 (2):279-292.
An Effective Intervention: Limiting Opioid Prescribing as a Means of Reducing Opioid Analgesic Misuse, and Overdose Deaths.Brandi C. Fink, Olivier Uyttebrouck & Richard S. Larson - 2020 - Journal of Law, Medicine and Ethics 48 (2):249-258.

Analytics

Added to PP
2014-02-02

Downloads
41 (#554,070)

6 months
8 (#622,456)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

The prescription opioid epidemic: an update.Geoffrey Poitras - 2018 - Medicolegal and Bioethics:21-32.

Add more citations

References found in this work

The myth of mental illness.Thomas S. Szasz - 2004 - In Arthur L. Caplan, James J. McCartney & Dominic A. Sisti (eds.), Health, Disease, and Illness: Concepts in Medicine. Georgetown University Press. pp. 43--50.
Ethics and the business of bioscience.Margaret L. Eaton - 2004 - Stanford, Calif.: Stanford Business Books.
Ethical Transparency and Economic Medicalization.Geoffrey Poitras & Lindsay Meredith - 2009 - Journal of Business Ethics 86 (3):313-325.

View all 8 references / Add more references